Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Investing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Investing Activities ₹4,561 Cr₹-528 Cr₹-333 Cr₹-675 Cr₹-784 Cr

What is the latest Cash Flow from Investing Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Investing Activities ratio of GLENMARK PHARMACEUTICALS is ₹4,561 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Investing Activities
Mar2024₹4,561 Cr
Mar2023₹-528 Cr
Mar2022₹-333 Cr
Mar2021₹-675 Cr
Mar2020₹-784 Cr

How is Cash Flow from Investing Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Investing Activities % Change
Mar2024 ₹4,561 Cr
Positive
Mar2023 ₹-528 Cr
Negative
Mar2022 ₹-333 Cr
Negative
Mar2021 ₹-675 Cr
Negative
Mar2020 ₹-784 Cr -

Compare Cash Flow from Investing Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,810.4 Cr 3.7% 5% 40.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,400.0 Cr -0.3% 3.1% 13.4% Stock Analytics
DIVIS LABORATORIES ₹164,844.0 Cr 3.5% 11% 63.5% Stock Analytics
CIPLA ₹121,328.0 Cr 1.6% 2.7% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,521.0 Cr 4.1% 4.4% 24.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,043.0 Cr 6.8% 11.3% 3.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.7%

5%

40.9%

SENSEX

2.7%

11.8%

14%


You may also like the below Video Courses